Industry Research Reports
Home > Reports > Pharma & Healthcare > Global Paliperidone Palmitate Long-Acting Injection Market Research Report 2026
Global Paliperidone Palmitate Long-Acting Injection Market Research Report 2026
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Paliperidone Palmitate Long-Acting Injection Market Size(US$)
CAGR 2026-2032
6.3%
Market Size,2032
USD 6,640
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 4,602 million
Market Forecast in 2032(Value)
US$ 6,640 million
CAGR
6.3%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Paliperidone Palmitate Long-Acting Injection market was valued at US$ 4355 million in 2025 and is anticipated to reach US$ 6640 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Paliperidone Palmitate Long-Acting Injection competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Paliperidone palmitate long-acting injection is a sustained-release antipsychotic injection, the main ingredient of which is paliperidone palmitate, a long-acting esterified form of paliperidone. The preparation is administered by intramuscular injection and can gradually hydrolyze and release active drugs in the body to achieve a sustained therapeutic effect. It is usually injected once a month for the treatment of schizophrenia and related mental disorders, which helps to improve patient compliance, reduce the risk of relapse and improve treatment stability.
The North American market for Paliperidone Palmitate Long-Acting Injection is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Paliperidone Palmitate Long-Acting Injection is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Paliperidone Palmitate Long-Acting Injection include Janssen Pharmaceuticals, Teva Pharmaceutical, Viatris, Sun Pharmaceutical, Cipla, Hikma Pharmaceuticals, Qilu Pharmaceutical, Hansoh Pharmaceuticak Group, Luye Pharma Group, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Paliperidone Palmitate Long-Acting Injection market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Paliperidone Palmitate Long-Acting Injection. The Paliperidone Palmitate Long-Acting Injection market size, estimates, and forecasts are provided in terms of sales volume (K Dose) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Paliperidone Palmitate Long-Acting Injection market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Paliperidone Palmitate Long-Acting Injection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
- Janssen Pharmaceuticals
- Teva Pharmaceutical
- Viatris
- Sun Pharmaceutical
- Cipla
- Hikma Pharmaceuticals
- Qilu Pharmaceutical
- Hansoh Pharmaceuticak Group
- Luye Pharma Group
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Monthly Dosage Form
- Quarterly Dosage Form
Segment by Application
- General Hospital
- Specialized Hospital
- Others
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Paliperidone Palmitate Long-Acting Injection manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Paliperidone Palmitate Long-Acting Injection sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Paliperidone Palmitate Long-Acting Injection Market Overview
1.1 Product Definition
1.2 Paliperidone Palmitate Long-Acting Injection by Type
1.2.1 Global Paliperidone Palmitate Long-Acting Injection Market Value by Type: 2025 vs 2032
1.2.2 Monthly Dosage Form
1.2.3 Quarterly Dosage Form
1.3 Paliperidone Palmitate Long-Acting Injection by Application
1.3.1 Global Paliperidone Palmitate Long-Acting Injection Market Value by Application: 2025 vs 2032
1.3.2 General Hospital
1.3.3 Specialized Hospital
1.3.4 Others
1.4 Global Paliperidone Palmitate Long-Acting Injection Market Size Estimates and Forecasts
1.4.1 Global Paliperidone Palmitate Long-Acting Injection Revenue 2021–2032
1.4.2 Global Paliperidone Palmitate Long-Acting Injection Sales 2021–2032
1.4.3 Global Paliperidone Palmitate Long-Acting Injection Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Paliperidone Palmitate Long-Acting Injection Market Competition by Manufacturers
2.1 Global Paliperidone Palmitate Long-Acting Injection Sales Market Share by Manufacturers (2021–2026)
2.2 Global Paliperidone Palmitate Long-Acting Injection Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Paliperidone Palmitate Long-Acting Injection Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Paliperidone Palmitate Long-Acting Injection, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Paliperidone Palmitate Long-Acting Injection, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Paliperidone Palmitate Long-Acting Injection, Product Types and Applications
2.7 Global Key Manufacturers of Paliperidone Palmitate Long-Acting Injection, Date of Entry into the Industry
2.8 Global Paliperidone Palmitate Long-Acting Injection Market Competitive Situation and Trends
2.8.1 Global Paliperidone Palmitate Long-Acting Injection Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Paliperidone Palmitate Long-Acting Injection Players Market Share by Revenue
2.8.3 Global Paliperidone Palmitate Long-Acting Injection Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Paliperidone Palmitate Long-Acting Injection Market Scenario by Region
3.1 Global Paliperidone Palmitate Long-Acting Injection Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Paliperidone Palmitate Long-Acting Injection Sales by Region: 2021–2032
3.2.1 Global Paliperidone Palmitate Long-Acting Injection Sales by Region: 2021–2026
3.2.2 Global Paliperidone Palmitate Long-Acting Injection Sales by Region: 2027–2032
3.3 Global Paliperidone Palmitate Long-Acting Injection Revenue by Region: 2021–2032
3.3.1 Global Paliperidone Palmitate Long-Acting Injection Revenue by Region: 2021–2026
3.3.2 Global Paliperidone Palmitate Long-Acting Injection Revenue by Region: 2027–2032
3.4 North America Paliperidone Palmitate Long-Acting Injection Market Facts & Figures by Country
3.4.1 North America Paliperidone Palmitate Long-Acting Injection Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Paliperidone Palmitate Long-Acting Injection Sales by Country (2021–2032)
3.4.3 North America Paliperidone Palmitate Long-Acting Injection Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Paliperidone Palmitate Long-Acting Injection Market Facts & Figures by Country
3.5.1 Europe Paliperidone Palmitate Long-Acting Injection Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Paliperidone Palmitate Long-Acting Injection Sales by Country (2021–2032)
3.5.3 Europe Paliperidone Palmitate Long-Acting Injection Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Paliperidone Palmitate Long-Acting Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Paliperidone Palmitate Long-Acting Injection Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Paliperidone Palmitate Long-Acting Injection Sales by Region (2021–2032)
3.6.3 Asia Pacific Paliperidone Palmitate Long-Acting Injection Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Paliperidone Palmitate Long-Acting Injection Market Facts & Figures by Country
3.7.1 Latin America Paliperidone Palmitate Long-Acting Injection Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Paliperidone Palmitate Long-Acting Injection Sales by Country (2021–2032)
3.7.3 Latin America Paliperidone Palmitate Long-Acting Injection Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Paliperidone Palmitate Long-Acting Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Paliperidone Palmitate Long-Acting Injection Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Paliperidone Palmitate Long-Acting Injection Sales by Country (2021–2032)
3.8.3 Middle East and Africa Paliperidone Palmitate Long-Acting Injection Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Paliperidone Palmitate Long-Acting Injection Sales by Type (2021–2032)
4.1.1 Global Paliperidone Palmitate Long-Acting Injection Sales by Type (2021–2026)
4.1.2 Global Paliperidone Palmitate Long-Acting Injection Sales by Type (2027–2032)
4.1.3 Global Paliperidone Palmitate Long-Acting Injection Sales Market Share by Type (2021–2032)
4.2 Global Paliperidone Palmitate Long-Acting Injection Revenue by Type (2021–2032)
4.2.1 Global Paliperidone Palmitate Long-Acting Injection Revenue by Type (2021–2026)
4.2.2 Global Paliperidone Palmitate Long-Acting Injection Revenue by Type (2027–2032)
4.2.3 Global Paliperidone Palmitate Long-Acting Injection Revenue Market Share by Type (2021–2032)
4.3 Global Paliperidone Palmitate Long-Acting Injection Price by Type (2021–2032)
5 Segment by Application
5.1 Global Paliperidone Palmitate Long-Acting Injection Sales by Application (2021–2032)
5.1.1 Global Paliperidone Palmitate Long-Acting Injection Sales by Application (2021–2026)
5.1.2 Global Paliperidone Palmitate Long-Acting Injection Sales by Application (2027–2032)
5.1.3 Global Paliperidone Palmitate Long-Acting Injection Sales Market Share by Application (2021–2032)
5.2 Global Paliperidone Palmitate Long-Acting Injection Revenue by Application (2021–2032)
5.2.1 Global Paliperidone Palmitate Long-Acting Injection Revenue by Application (2021–2026)
5.2.2 Global Paliperidone Palmitate Long-Acting Injection Revenue by Application (2027–2032)
5.2.3 Global Paliperidone Palmitate Long-Acting Injection Revenue Market Share by Application (2021–2032)
5.3 Global Paliperidone Palmitate Long-Acting Injection Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Janssen Pharmaceuticals
6.1.1 Janssen Pharmaceuticals Company Information
6.1.2 Janssen Pharmaceuticals Description and Business Overview
6.1.3 Janssen Pharmaceuticals Paliperidone Palmitate Long-Acting Injection Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Janssen Pharmaceuticals Paliperidone Palmitate Long-Acting Injection Product Portfolio
6.1.5 Janssen Pharmaceuticals Recent Developments/Updates
6.2 Teva Pharmaceutical
6.2.1 Teva Pharmaceutical Company Information
6.2.2 Teva Pharmaceutical Description and Business Overview
6.2.3 Teva Pharmaceutical Paliperidone Palmitate Long-Acting Injection Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Teva Pharmaceutical Paliperidone Palmitate Long-Acting Injection Product Portfolio
6.2.5 Teva Pharmaceutical Recent Developments/Updates
6.3 Viatris
6.3.1 Viatris Company Information
6.3.2 Viatris Description and Business Overview
6.3.3 Viatris Paliperidone Palmitate Long-Acting Injection Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Viatris Paliperidone Palmitate Long-Acting Injection Product Portfolio
6.3.5 Viatris Recent Developments/Updates
6.4 Sun Pharmaceutical
6.4.1 Sun Pharmaceutical Company Information
6.4.2 Sun Pharmaceutical Description and Business Overview
6.4.3 Sun Pharmaceutical Paliperidone Palmitate Long-Acting Injection Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Sun Pharmaceutical Paliperidone Palmitate Long-Acting Injection Product Portfolio
6.4.5 Sun Pharmaceutical Recent Developments/Updates
6.5 Cipla
6.5.1 Cipla Company Information
6.5.2 Cipla Description and Business Overview
6.5.3 Cipla Paliperidone Palmitate Long-Acting Injection Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Cipla Paliperidone Palmitate Long-Acting Injection Product Portfolio
6.5.5 Cipla Recent Developments/Updates
6.6 Hikma Pharmaceuticals
6.6.1 Hikma Pharmaceuticals Company Information
6.6.2 Hikma Pharmaceuticals Description and Business Overview
6.6.3 Hikma Pharmaceuticals Paliperidone Palmitate Long-Acting Injection Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Hikma Pharmaceuticals Paliperidone Palmitate Long-Acting Injection Product Portfolio
6.6.5 Hikma Pharmaceuticals Recent Developments/Updates
6.7 Qilu Pharmaceutical
6.7.1 Qilu Pharmaceutical Company Information
6.7.2 Qilu Pharmaceutical Description and Business Overview
6.7.3 Qilu Pharmaceutical Paliperidone Palmitate Long-Acting Injection Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Qilu Pharmaceutical Paliperidone Palmitate Long-Acting Injection Product Portfolio
6.7.5 Qilu Pharmaceutical Recent Developments/Updates
6.8 Hansoh Pharmaceuticak Group
6.8.1 Hansoh Pharmaceuticak Group Company Information
6.8.2 Hansoh Pharmaceuticak Group Description and Business Overview
6.8.3 Hansoh Pharmaceuticak Group Paliperidone Palmitate Long-Acting Injection Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Hansoh Pharmaceuticak Group Paliperidone Palmitate Long-Acting Injection Product Portfolio
6.8.5 Hansoh Pharmaceuticak Group Recent Developments/Updates
6.9 Luye Pharma Group
6.9.1 Luye Pharma Group Company Information
6.9.2 Luye Pharma Group Description and Business Overview
6.9.3 Luye Pharma Group Paliperidone Palmitate Long-Acting Injection Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Luye Pharma Group Paliperidone Palmitate Long-Acting Injection Product Portfolio
6.9.5 Luye Pharma Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Paliperidone Palmitate Long-Acting Injection Industry Chain Analysis
7.2 Paliperidone Palmitate Long-Acting Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Paliperidone Palmitate Long-Acting Injection Production Mode & Process Analysis
7.4 Paliperidone Palmitate Long-Acting Injection Sales and Marketing
7.4.1 Paliperidone Palmitate Long-Acting Injection Sales Channels
7.4.2 Paliperidone Palmitate Long-Acting Injection Distributors
7.5 Paliperidone Palmitate Long-Acting Injection Customer Analysis
8 Paliperidone Palmitate Long-Acting Injection Market Dynamics
8.1 Paliperidone Palmitate Long-Acting Injection Industry Trends
8.2 Paliperidone Palmitate Long-Acting Injection Market Drivers
8.3 Paliperidone Palmitate Long-Acting Injection Market Challenges
8.4 Paliperidone Palmitate Long-Acting Injection Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Table of Figures
List of Tables
Table 1. Global Paliperidone Palmitate Long-Acting Injection Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Paliperidone Palmitate Long-Acting Injection Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Paliperidone Palmitate Long-Acting Injection Market Competitive Situation by Manufacturers in 2025
Table 4. Global Paliperidone Palmitate Long-Acting Injection Sales (K Dose) of Key Manufacturers (2021–2026)
Table 5. Global Paliperidone Palmitate Long-Acting Injection Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Paliperidone Palmitate Long-Acting Injection Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Paliperidone Palmitate Long-Acting Injection Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Paliperidone Palmitate Long-Acting Injection Average Price (US$/Dose) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Paliperidone Palmitate Long-Acting Injection, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Paliperidone Palmitate Long-Acting Injection, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Paliperidone Palmitate Long-Acting Injection, Product Types and Applications
Table 12. Global Key Manufacturers of Paliperidone Palmitate Long-Acting Injection, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Paliperidone Palmitate Long-Acting Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on Paliperidone Palmitate Long-Acting Injection Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Paliperidone Palmitate Long-Acting Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Paliperidone Palmitate Long-Acting Injection Sales by Region (K Dose), 2021–2026
Table 18. Global Paliperidone Palmitate Long-Acting Injection Sales Market Share by Region (2021–2026)
Table 19. Global Paliperidone Palmitate Long-Acting Injection Sales by Region (K Dose), 2027–2032
Table 20. Global Paliperidone Palmitate Long-Acting Injection Sales Market Share by Region (2027–2032)
Table 21. Global Paliperidone Palmitate Long-Acting Injection Revenue by Region (US$ Million), 2021–2026
Table 22. Global Paliperidone Palmitate Long-Acting Injection Revenue Market Share by Region (2021–2026)
Table 23. Global Paliperidone Palmitate Long-Acting Injection Revenue by Region (US$ Million), 2027–2032
Table 24. Global Paliperidone Palmitate Long-Acting Injection Revenue Market Share by Region (2027–2032)
Table 25. North America Paliperidone Palmitate Long-Acting Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Paliperidone Palmitate Long-Acting Injection Sales by Country (K Dose), 2021–2026
Table 27. North America Paliperidone Palmitate Long-Acting Injection Sales by Country (K Dose), 2027–2032
Table 28. North America Paliperidone Palmitate Long-Acting Injection Revenue by Country (US$ Million), 2021–2026
Table 29. North America Paliperidone Palmitate Long-Acting Injection Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Paliperidone Palmitate Long-Acting Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Paliperidone Palmitate Long-Acting Injection Sales by Country (K Dose), 2021–2026
Table 32. Europe Paliperidone Palmitate Long-Acting Injection Sales by Country (K Dose), 2027–2032
Table 33. Europe Paliperidone Palmitate Long-Acting Injection Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Paliperidone Palmitate Long-Acting Injection Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Paliperidone Palmitate Long-Acting Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Paliperidone Palmitate Long-Acting Injection Sales by Region (K Dose), 2021–2026
Table 37. Asia Pacific Paliperidone Palmitate Long-Acting Injection Sales by Region (K Dose), 2027–2032
Table 38. Asia Pacific Paliperidone Palmitate Long-Acting Injection Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Paliperidone Palmitate Long-Acting Injection Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Paliperidone Palmitate Long-Acting Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Paliperidone Palmitate Long-Acting Injection Sales by Country (K Dose), 2021–2026
Table 42. Latin America Paliperidone Palmitate Long-Acting Injection Sales by Country (K Dose), 2027–2032
Table 43. Latin America Paliperidone Palmitate Long-Acting Injection Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Paliperidone Palmitate Long-Acting Injection Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Paliperidone Palmitate Long-Acting Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Paliperidone Palmitate Long-Acting Injection Sales by Country (K Dose), 2021–2026
Table 47. Middle East and Africa Paliperidone Palmitate Long-Acting Injection Sales by Country (K Dose), 2027–2032
Table 48. Middle East and Africa Paliperidone Palmitate Long-Acting Injection Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Paliperidone Palmitate Long-Acting Injection Revenue by Country (US$ Million), 2027–2032
Table 50. Global Paliperidone Palmitate Long-Acting Injection Sales (K Dose) by Type (2021–2026)
Table 51. Global Paliperidone Palmitate Long-Acting Injection Sales (K Dose) by Type (2027–2032)
Table 52. Global Paliperidone Palmitate Long-Acting Injection Sales Market Share by Type (2021–2026)
Table 53. Global Paliperidone Palmitate Long-Acting Injection Sales Market Share by Type (2027–2032)
Table 54. Global Paliperidone Palmitate Long-Acting Injection Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Paliperidone Palmitate Long-Acting Injection Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Paliperidone Palmitate Long-Acting Injection Revenue Market Share by Type (2021–2026)
Table 57. Global Paliperidone Palmitate Long-Acting Injection Revenue Market Share by Type (2027–2032)
Table 58. Global Paliperidone Palmitate Long-Acting Injection Price (US$/Dose) by Type (2021–2026)
Table 59. Global Paliperidone Palmitate Long-Acting Injection Price (US$/Dose) by Type (2027–2032)
Table 60. Global Paliperidone Palmitate Long-Acting Injection Sales (K Dose) by Application (2021–2026)
Table 61. Global Paliperidone Palmitate Long-Acting Injection Sales (K Dose) by Application (2027–2032)
Table 62. Global Paliperidone Palmitate Long-Acting Injection Sales Market Share by Application (2021–2026)
Table 63. Global Paliperidone Palmitate Long-Acting Injection Sales Market Share by Application (2027–2032)
Table 64. Global Paliperidone Palmitate Long-Acting Injection Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Paliperidone Palmitate Long-Acting Injection Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Paliperidone Palmitate Long-Acting Injection Revenue Market Share by Application (2021–2026)
Table 67. Global Paliperidone Palmitate Long-Acting Injection Revenue Market Share by Application (2027–2032)
Table 68. Global Paliperidone Palmitate Long-Acting Injection Price (US$/Dose) by Application (2021–2026)
Table 69. Global Paliperidone Palmitate Long-Acting Injection Price (US$/Dose) by Application (2027–2032)
Table 70. Janssen Pharmaceuticals Company Information
Table 71. Janssen Pharmaceuticals Description and Business Overview
Table 72. Janssen Pharmaceuticals Paliperidone Palmitate Long-Acting Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 73. Janssen Pharmaceuticals Paliperidone Palmitate Long-Acting Injection Product
Table 74. Janssen Pharmaceuticals Recent Developments/Updates
Table 75. Teva Pharmaceutical Company Information
Table 76. Teva Pharmaceutical Description and Business Overview
Table 77. Teva Pharmaceutical Paliperidone Palmitate Long-Acting Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 78. Teva Pharmaceutical Paliperidone Palmitate Long-Acting Injection Product
Table 79. Teva Pharmaceutical Recent Developments/Updates
Table 80. Viatris Company Information
Table 81. Viatris Description and Business Overview
Table 82. Viatris Paliperidone Palmitate Long-Acting Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 83. Viatris Paliperidone Palmitate Long-Acting Injection Product
Table 84. Viatris Recent Developments/Updates
Table 85. Sun Pharmaceutical Company Information
Table 86. Sun Pharmaceutical Description and Business Overview
Table 87. Sun Pharmaceutical Paliperidone Palmitate Long-Acting Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 88. Sun Pharmaceutical Paliperidone Palmitate Long-Acting Injection Product
Table 89. Sun Pharmaceutical Recent Developments/Updates
Table 90. Cipla Company Information
Table 91. Cipla Description and Business Overview
Table 92. Cipla Paliperidone Palmitate Long-Acting Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 93. Cipla Paliperidone Palmitate Long-Acting Injection Product
Table 94. Cipla Recent Developments/Updates
Table 95. Hikma Pharmaceuticals Company Information
Table 96. Hikma Pharmaceuticals Description and Business Overview
Table 97. Hikma Pharmaceuticals Paliperidone Palmitate Long-Acting Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 98. Hikma Pharmaceuticals Paliperidone Palmitate Long-Acting Injection Product
Table 99. Hikma Pharmaceuticals Recent Developments/Updates
Table 100. Qilu Pharmaceutical Company Information
Table 101. Qilu Pharmaceutical Description and Business Overview
Table 102. Qilu Pharmaceutical Paliperidone Palmitate Long-Acting Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 103. Qilu Pharmaceutical Paliperidone Palmitate Long-Acting Injection Product
Table 104. Qilu Pharmaceutical Recent Developments/Updates
Table 105. Hansoh Pharmaceuticak Group Company Information
Table 106. Hansoh Pharmaceuticak Group Description and Business Overview
Table 107. Hansoh Pharmaceuticak Group Paliperidone Palmitate Long-Acting Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 108. Hansoh Pharmaceuticak Group Paliperidone Palmitate Long-Acting Injection Product
Table 109. Hansoh Pharmaceuticak Group Recent Developments/Updates
Table 110. Luye Pharma Group Company Information
Table 111. Luye Pharma Group Description and Business Overview
Table 112. Luye Pharma Group Paliperidone Palmitate Long-Acting Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 113. Luye Pharma Group Paliperidone Palmitate Long-Acting Injection Product
Table 114. Luye Pharma Group Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Paliperidone Palmitate Long-Acting Injection Distributors List
Table 118. Paliperidone Palmitate Long-Acting Injection Customers List
Table 119. Paliperidone Palmitate Long-Acting Injection Market Trends
Table 120. Paliperidone Palmitate Long-Acting Injection Market Drivers
Table 121. Paliperidone Palmitate Long-Acting Injection Market Challenges
Table 122. Paliperidone Palmitate Long-Acting Injection Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Paliperidone Palmitate Long-Acting Injection
Figure 2. Global Paliperidone Palmitate Long-Acting Injection Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Paliperidone Palmitate Long-Acting Injection Market Share by Type: 2025 & 2032
Figure 4. Monthly Dosage Form Product Picture
Figure 5. Quarterly Dosage Form Product Picture
Figure 6. Global Paliperidone Palmitate Long-Acting Injection Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Paliperidone Palmitate Long-Acting Injection Market Share by Application: 2025 & 2032
Figure 8. General Hospital
Figure 9. Specialized Hospital
Figure 10. Others
Figure 11. Global Paliperidone Palmitate Long-Acting Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Paliperidone Palmitate Long-Acting Injection Market Size (US$ Million), 2021–2032
Figure 13. Global Paliperidone Palmitate Long-Acting Injection Sales (K Dose), 2021–2032
Figure 14. Global Paliperidone Palmitate Long-Acting Injection Average Price (US$/Dose), 2021–2032
Figure 15. Paliperidone Palmitate Long-Acting Injection Report Years Considered
Figure 16. Paliperidone Palmitate Long-Acting Injection Sales Share by Manufacturers in 2025
Figure 17. Global Paliperidone Palmitate Long-Acting Injection Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Paliperidone Palmitate Long-Acting Injection Players: Market Share by Revenue in Paliperidone Palmitate Long-Acting Injection in 2025
Figure 19. Paliperidone Palmitate Long-Acting Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Paliperidone Palmitate Long-Acting Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Paliperidone Palmitate Long-Acting Injection Sales Market Share by Country (2021–2032)
Figure 22. North America Paliperidone Palmitate Long-Acting Injection Revenue Market Share by Country (2021–2032)
Figure 23. United States Paliperidone Palmitate Long-Acting Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Paliperidone Palmitate Long-Acting Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Paliperidone Palmitate Long-Acting Injection Sales Market Share by Country (2021–2032)
Figure 26. Europe Paliperidone Palmitate Long-Acting Injection Revenue Market Share by Country (2021–2032)
Figure 27. Germany Paliperidone Palmitate Long-Acting Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Paliperidone Palmitate Long-Acting Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Paliperidone Palmitate Long-Acting Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Paliperidone Palmitate Long-Acting Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Paliperidone Palmitate Long-Acting Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Paliperidone Palmitate Long-Acting Injection Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Paliperidone Palmitate Long-Acting Injection Revenue Market Share by Region (2021–2032)
Figure 34. China Paliperidone Palmitate Long-Acting Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Paliperidone Palmitate Long-Acting Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Paliperidone Palmitate Long-Acting Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Paliperidone Palmitate Long-Acting Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Paliperidone Palmitate Long-Acting Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Paliperidone Palmitate Long-Acting Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Paliperidone Palmitate Long-Acting Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Paliperidone Palmitate Long-Acting Injection Sales Market Share by Country (2021–2032)
Figure 42. Latin America Paliperidone Palmitate Long-Acting Injection Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Paliperidone Palmitate Long-Acting Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Paliperidone Palmitate Long-Acting Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Paliperidone Palmitate Long-Acting Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Paliperidone Palmitate Long-Acting Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Paliperidone Palmitate Long-Acting Injection Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Paliperidone Palmitate Long-Acting Injection Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Paliperidone Palmitate Long-Acting Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Paliperidone Palmitate Long-Acting Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Paliperidone Palmitate Long-Acting Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Paliperidone Palmitate Long-Acting Injection by Type (2021–2032)
Figure 53. Global Revenue Market Share of Paliperidone Palmitate Long-Acting Injection by Type (2021–2032)
Figure 54. Global Paliperidone Palmitate Long-Acting Injection Price (US$/Dose) by Type (2021–2032)
Figure 55. Global Sales Market Share of Paliperidone Palmitate Long-Acting Injection by Application (2021–2032)
Figure 56. Global Revenue Market Share of Paliperidone Palmitate Long-Acting Injection by Application (2021–2032)
Figure 57. Global Paliperidone Palmitate Long-Acting Injection Price (US$/Dose) by Application (2021–2032)
Figure 58. Paliperidone Palmitate Long-Acting Injection Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Related Reports
Global Paliperidone Palmitate Long-Acting Injection Market Insights, Forecast to 2031
The global Paliperidone Palmitate Long-Acting Injection market is projected to grow from US$ 4355 million in 2025 to US$ 6283 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.3% during the forecast period.
Published Date: 2025-04-25
Pages: 141
USD 4900.00
(Single User License)
Paliperidone Palmitate Long-Acting Injection - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Paliperidone Palmitate Long-Acting Injection was estimated to be worth US$ 4115 million in 2024 and is forecast to a readjusted size of US$ 6283 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published Date: 2025-04-25
Pages: 95
USD 3950.00
(Single User License)
Global Paliperidone Palmitate Long-Acting Injection Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Paliperidone Palmitate Long-Acting Injection market size was US$ 4115 million in 2024 and is forecast to a readjusted size of US$ 6283 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published Date: 2025-04-25
Pages: 80
USD 4250.00
(Single User License)
Global Paliperidone Palmitate Long-Acting Injection Market Research Report 2025
The global market for Paliperidone Palmitate Long-Acting Injection was valued at US$ 4115 million in the year 2024 and is projected to reach a revised size of US$ 6283 million by 2031, growing at a CAGR of 6.3% during the forecast period.
Published Date: 2025-04-25
Pages: 83
USD 2900.00
(Single User License)
Paliperidone Palmitate Long-Acting Injection- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Paliperidone Palmitate Long-Acting Injection was estimated to be worth US$ 4355 million in 2025 and is projected to reach US$ 6640 million, growing at a CAGR of 6.3% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 99
USD 3950.00
(Single User License)
Global Paliperidone Palmitate Long-Acting Injection Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Paliperidone Palmitate Long-Acting Injection market size was US$ 4355 million in 2025 and is forecast to reach a readjusted size of US$ 6640 million by 2032 with a CAGR of 6.3% during the forecast period 2026-2032.
Published Date: 2026-03-11
Pages: 80
USD 4250.00
(Single User License)
Global Paliperidone Palmitate Long-Acting Injection Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Paliperidone Palmitate Long-Acting Injection market is projected to grow from US$ 4355 million in 2025 to US$ 6640 million by 2032, at a CAGR of 6.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-11
Pages: 147
USD 4900.00
(Single User License)
Global Paliperidone Palmitate Long-Acting Injection Market Insights, Forecast to 2031
The global Paliperidone Palmitate Long-Acting Injection market is projected to grow from US$ 4355 million in 2025 to US$ 6283 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.3% during the forecast period.
Published: 2025-04-25
Pages: 141
USD 4900.00 (Single User License)Paliperidone Palmitate Long-Acting Injection - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Paliperidone Palmitate Long-Acting Injection was estimated to be worth US$ 4115 million in 2024 and is forecast to a readjusted size of US$ 6283 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published: 2025-04-25
Pages: 95
USD 3950.00 (Single User License)Global Paliperidone Palmitate Long-Acting Injection Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Paliperidone Palmitate Long-Acting Injection market size was US$ 4115 million in 2024 and is forecast to a readjusted size of US$ 6283 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published: 2025-04-25
Pages: 80
USD 4250.00 (Single User License)Global Paliperidone Palmitate Long-Acting Injection Market Research Report 2025
The global market for Paliperidone Palmitate Long-Acting Injection was valued at US$ 4115 million in the year 2024 and is projected to reach a revised size of US$ 6283 million by 2031, growing at a CAGR of 6.3% during the forecast period.
Published: 2025-04-25
Pages: 83
USD 2900.00 (Single User License)Paliperidone Palmitate Long-Acting Injection- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Paliperidone Palmitate Long-Acting Injection was estimated to be worth US$ 4355 million in 2025 and is projected to reach US$ 6640 million, growing at a CAGR of 6.3% from 2026 to 2032.
Published: 2026-03-09
Pages: 99
USD 3950.00 (Single User License)Global Paliperidone Palmitate Long-Acting Injection Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Paliperidone Palmitate Long-Acting Injection market size was US$ 4355 million in 2025 and is forecast to reach a readjusted size of US$ 6640 million by 2032 with a CAGR of 6.3% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 80
USD 4250.00 (Single User License)Global Paliperidone Palmitate Long-Acting Injection Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Paliperidone Palmitate Long-Acting Injection market is projected to grow from US$ 4355 million in 2025 to US$ 6640 million by 2032, at a CAGR of 6.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-11
Pages: 147
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
Market Segmentation
Why This Report?
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research